《LANCET,5月15日,Tracheostomy in the COVID-19 era: global and multidisciplinary guidance》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-05-16
  • Tracheostomy in the COVID-19 era: global and multidisciplinary guidance

    Brendan A McGrath, PhD †

    Michael J Brenner, MD †

    Stephen J Warrillow, PhD

    Vinciya Pandian, PhD

    Asit Arora, PhD

    Tanis S Cameron, MA

    et al.

    Show all authors

    Show footnotes

    Published:May 15, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30230-7

    Global health care is experiencing an unprecedented surge in the number of critically ill patients who require mechanical ventilation due to the COVID-19 pandemic. The requirement for relatively long periods of ventilation in those who survive means that many are considered for tracheostomy to free patients from ventilatory support and maximise scarce resources. COVID-19 provides unique challenges for tracheostomy care: health-care workers need to safely undertake tracheostomy procedures and manage patients afterwards, minimising risks of nosocomial transmission and compromises in the quality of care. Conflicting recommendations exist about case selection, the timing and performance of tracheostomy, and the subsequent management of patients. In response, we convened an international working group of individuals with relevant expertise in tracheostomy. We did a literature and internet search for reports of research pertaining to tracheostomy during the COVID-19 pandemic, supplemented by sources comprising statements and guidance on tracheostomy care. By synthesising early experiences from countries that have managed a surge in patient numbers, emerging virological data, and international, multidisciplinary expert opinion, we aim to provide consensus guidelines and recommendations on the conduct and management of tracheostomy during the COVID-19 pandemic.

  • 原文来源:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30230-7/fulltext
相关报告
  • 《Lancet,3月24日,Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-25
    • Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility Maimuna S Majumder Kenneth D Mandl Open AccessPublished:March 24, 2020DOI:https://doi.org/10.1016/S2214-109X(20)30113-3 Since it was first reported by WHO in Jan 5, 2020, over 80?000 cases of a novel coronavirus disease (COVID-19) have been diagnosed in China, with exportation events to nearly 90 countries, as of March 6, 2020.1 Given the novelty of the causative pathogen (named SARS-CoV-2), scientists have rushed to fill epidemiological, virological, and clinical knowledge gaps—resulting in over 50 new studies about the virus between January 10 and January 30 alone.2 However, in an era where the immediacy of information has become an expectation of decision makers and the general public alike, many of these studies have been shared first in the form of preprint papers—before peer review.
  • 《CID,5月15日,An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-17
    • An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19 Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, Germana Grassi, Eleonora Tartaglia, Rita Casetti, Letizia Giancola, Nazario Bevilacqua, Markus Maeurer ... Show moreAuthor Notes Clinical Infectious Diseases, ciaa577, https://doi.org/10.1093/cid/ciaa577 Published: 15 May 2020 Article history Abstract Increased production of inflammatory cytokines and myeloid-derived suppressor cells occur in COVID-19 patients. These inversely correlated with perforin-expressing NK and CD3+T-cells. We observed a lower perforin+ NK cells number in intensive care unit (ICU) compared to non-ICU patients, suggesting an impairment of the immune cytotoxic arm as a pathogenic mechanism.